Drug Type CAR-T |
Synonyms- |
Mechanism HPK1 inhibitors(Mitogen-activated protein kinase kinase kinase kinase 1 inhibitors), Lewis-Y antigen inhibitors(Lewis-Y antigen inhibitors), PD-1 inhibitors(Programmed cell death protein 1 inhibitors) + [2] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Phase 1 | CN | 01 Jul 2017 |